SUNNYVALE, CA – June 29, 2011 – (Motor Sports Newswire) – Cepheid (NASDAQ: CPHD) today announces ‘Art Meets Innovation,’ an innovative teaming of Cepheid and Paul Jr. Designs for the unveiling of new Cepheid products at the 2011 American Association of Clinical Chemistry and Clinical Lab Expo, to be held in Atlanta, GA. this July 24-28. At ‘Art Meets Innovation,’ a Cepheid themed project designed and built by Paul Jr. Designs will be unveiled live alongside Cepheid’s new products. The event will take place at 10am on July 26th at Cepheid booth #431.
“Cepheid is the ideal company for us to work with — they have revolutionary technology, their products are impacting people around the world, and they are the fastest growing company in their industry,” said Paul Teutul Jr., Chief Executive Officer of Paul Jr. Designs. “We are excited to be a part of telling their story as they unveil these new products.”
Additionally, the ‘Art Meets Innovation’ unveiling event will be filmed live for inclusion on the popular Discovery Channel show American Chopper. The two-part episode featuring Cepheid is expected to air in the fourth quarter of this year.
“As the leading innovator in the Molecular Diagnostics market, we thought that it would be interesting and exciting to team with the leading innovator in creative design in his particular field through our engagement with Paul Jr. Designs. It’s an unexpected but perfect way to highlight our vision, innovation and creativity, associated with our new product offerings to be unveiled at the AACC/ASCLS meeting,” said John Bishop, Cepheid’s Chief Executive Officer. “We believe these unveilings will truly capture our company and brand like no other before it, along with the additional benefit of the expected halo effect of the Discovery Channel’s worldwide reach.”
Following ‘Art Meets Innovation,’ the Paul Jr. Designs project will play a key role in helping Cepheid promote its new products throughout the United States. Running updates on Cepheid’s promotional efforts can be found at www.cepheidinnovation.com or by following the company on Twitter at http://www.twitter.com/cepheidnews.
Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.
About Paul Jr. Designs
Although, Paul Jr. has always been mechanically inclined, it wasn’t until he was 25 that he realized the depth of his creativity. In 1999, he created the now world-famous logo for Orange County Choppers, a custom motorcycle business he co-founded in upstate New York. With his talent and eye for design, he went on to create some of the most recognizable theme choppers in the world, including the Black Widow Bike, the Fire Bike and the Jet Bike, as well as working with some of the top companies in the world such as Intel, NASA and Gillette. After ten years in the steel business and ten years building custom motorcycles and a brand through OCC, he is taking all he has learned and applying it to his new company, Paul Jr. Designs. For more information visit http://www.pauljrdesigns.com.
This press release contains forward-looking statements that are not purely historical regarding Cepheid’s or its management’s intentions, beliefs, expectations and strategies for the future, including those relating to planned new product releases, product performance and future market opportunities. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the company’s current expectations. Factors that could cause actual results to differ materially include risks and uncertainties such as those relating to: unforeseen manufacturing problems; uncertainties in the regulatory review process for new products; regulatory developments and practices regarding testing levels; customer and market acceptance of our products; the failure of products to perform as fast or as accurately as expected, whether due to manufacturing errors, defects or otherwise; the impact of competitive products and pricing; potentially lengthy sales cycles in some markets; reimbursement rates for the products; and underlying market conditions worldwide. Readers should also refer to the section entitled “Risk Factors” in Cepheid’s Annual Report on Form 10-K for 2010 and in its most recent quarterly report on Form 10-Q, each filed with the Securities and Exchange Commission.
All forward-looking statements and reasons why results might differ included in this release are made as of the date of this press release, based on information currently available to Cepheid, and Cepheid assumes no obligation to update any such forward-looking statement or reasons why results might differ.